This study is to investigate the changes in the volume of the prostate that occur when a patient is undergoing hormone therapy prior to radiotherapy. This is a combined study between Genesis Cancer Care (Radiation oncology providers) and South Coast Radiology. The prostate size is measured via a series of MRI scans.
The scans are provided by South Coast Radiology and funding for support for the study is provided by Ipsen, who manufacture Diphereline (a LHRH agonist that is used in treatment of prostate cancer). There are no out of pocket expenses for patients involved in the study. The study will include 50 patients and it will investigate correlations between changes in the volume of the prostate and changes in the levels of PSA and Testosterone determined by blood tests.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
If you are interested, please indicate this to your urologist who will be happy to facilitate things further.